- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Discrete Dynamics in Nature and Society
Volume 2013 (2013), Article ID 176956, 7 pages
Bifurcations and Dynamics of Cancer Signaling Network Regulated by MicroRNA
1School of Mathematics and Statistics, Zhengzhou University, Zhengzhou 450000, China
2Institute of Applied Mathematics, Xuchang University, Xuchang, Henan 461000, China
Received 27 August 2013; Revised 23 October 2013; Accepted 6 November 2013
Academic Editor: Jinde Cao
Copyright © 2013 Qianqian Zheng and Jianwei Shen. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- V. Ambros, “The functions of animal microRNAs,” Nature, vol. 431, no. 7006, pp. 350–355, 2004.
- N. Li, H. Fu, Y. Tie et al., “miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells,” Cancer Letters, vol. 275, no. 1, pp. 44–53, 2009.
- O. Merkel, D. Asslaber, J. D. Piñón, A. Egle, and R. Greil, “Interdependent regulation of p53 and miR-34a in chronic lymphocytic leukemia,” Cell Cycle, vol. 9, no. 14, pp. 2764–2768, 2010.
- V. Tarasov, P. Jung, B. Verdoodt et al., “Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G 1-arrest,” Cell Cycle, vol. 6, no. 13, pp. 1586–1593, 2007.
- K. Bhatt, L. Zhou, Q.-S. Mi, S. Huang, J.-X. She, and Z. Dong, “MicroRNA-34a is induced via p53 during cisplatin nephrotoxicity and contributes to cell survival,” Molecular Medicine, vol. 16, no. 9-10, pp. 409–416, 2010.
- X. Yu, W. Zhang, Q. Ning, et al., “Effect of mir-34 mimics transfected human brain glioma cell line U87 on expression of Dll1 gene,” Journal of Applied Clinical Pediatrics, vol. 26, no. 15, pp. 1161–1163, 2011.
- X. Sun, C. Huang, Y. Tu, et al., “Regulation of the cell cycle by mir-34a in the radiation damage response,” Journal of Soochow University, vol. 31, no. 3, pp. 335–338, 2011.
- M. H. G. Kubbutat, S. N. Jones, and K. H. Vousden, “Regulation of p53 stability by Mdm2,” Nature, vol. 387, no. 6630, pp. 299–303, 1997.
- M. Ashcroft and K. H. Vousden, “Regulation of p53 stability,” Oncogene, vol. 18, no. 53, pp. 7637–7643, 1999.
- H. Kitano, “Biological robustness,” Nature Reviews Genetics, vol. 5, no. 11, pp. 826–837, 2004.
- X. Lai, V. Julio, and O. Wolkenhauer, “Modeling miRNA regulation in signaling networks: mir-34a regulation of the p53/sirt1 module,” Nature Precedings, vol. 5123, p. 1, 2010.
- C. Liu, K. Kelnar, B. Liu et al., “The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44,” Nature Medicine, vol. 17, no. 2, pp. 211–216, 2011.